Metabolites for the 27 compounds used in this analysis and their amount in human circulation and excreta
The amount in circulation or excreta are included only if values exceed 10%.
Compound Name | In Vivo Human Metabolites | Phase 1 or 2 | Primary or Secondary Metabolite | Percentage in Excreta | Percentage of Circulating Radioactivity |
---|---|---|---|---|---|
Gemcabene | Gemcabene glucuronide | 2 | 1 | 44 | |
Avasimibe | Dehydrogenated avasimibe | 1 | 1 | 16 | |
Hydroxyavasimibe | 1 | 1 | 10 | ||
Pagoclone | Hydroxypagoclone | 1 | 1 | 65 | |
Axitinib | Hydroxyaxitinib | 1 | 1 | 11 | |
Axitinib sulfoxide | 1 | 1 | 16 | ||
Axitinib glucuronide | 2 | 1 | 50 | ||
Capravirine | Hydroxycapravirine sulfoxide | 1 | 2 | 11 | |
Hydroxycapraivirinesulfone N-oxide | 1 | 2 | 10 | ||
CJ-13610 | CJ-13610 sulfoxide | 1 | 1 | 36 | 17 |
CJ-13610 sulfone | 1 | 2 | 21 | 10 | |
Traxoprodil | Traxoprodil methoxy sulfate | 2 | 2 | 40 | 28 |
Traxoprodil methoxy glucuronide | 2 | 2 | 10 | 18 | |
CP-122721 | Desmethyl CP-122721 glucuronide | 2 | 2 | 27 | 14 |
N-Dealkylated CP-122721 glucuronide | 2 | 2 | 11 | ||
DesmethylhydroxyCP-122721 glucuronide | 2 | 2 | 25 | ||
5-Trifluoromethoxysalicylic acid | 1 | 2 | 56 | ||
Tofimulast | Dihydroxytofimulast | 1 | 2 | 23 | 14 |
Ring-opened tofimulast | 1 | 2 | 33 | ||
Desthiophene tofimulast | 1 | 2 | 13 | ||
Lasofoxifene | Lasofoxifene glucuronide | 2 | 1 | 22 | |
Capromorelin | Carboxylic acid of capromorelin | 1 | 2 | 11 | 14 |
O-Debenzyl hydroxycapromorelin | 1 | 2 | 12 | ||
Carboxylic acid of N-desmethyl-O-debenzylcapromorelin | 1 | 2 | 12 | ||
N-Desmethyl-O-debenzyl hydroxycapromorelin | 1 | 2 | 15 | ||
Torcetrapib | Bistrifluoromethyl benzoic acid | 1 | 2 | 50 | 50 |
7-Trifluoromethylquinaldic acid | 1 | 2 | 29 | 63 | |
CP-533536 | Hydroxy CP-533536 | 1 | 1 | 70 | |
CP-533536 sulfate | 2 | 1 | 11 | ||
CP-547632 | N-Dealkyl CP-547632 | 1 | 1 | 15 | |
Zoniporide | Hydroxyzoniporide | 1 | 1 | 52 | 64 |
Carboxylic acid of zoniporide | 1 | 2 | 17 | ||
Celecoxib | Carboxylic acid of celecoxib | 1 | 2 | 73 | 20 |
Celecoxib glucuronide | 2 | 2 | 15 | ||
CP-690550 | Hydroxy CP-690550 | 1 | 1 | 20 | 12 |
Dihydroxy CP-690550 | 1 | 2 | 12 | 12 | |
Dihydroxy CP-690550 glucuronide | 2 | 2 | 11 | 13 | |
Ziprasidone | Ziprasidone sulfoxide | 1 | 1 | 18 | 69 |
S-Methyldihydroziprasidone | 1 | 2 | 18 | 69 | |
N-Dealkylziprasidone S-oxide | 1 | 2 | 11 | 21 | |
N-Dealkylziprasidone sulfone | 1 | 2 | 11 | 21 | |
Sunepitron | Hydroxysunepitron | 1 | 1 | 17 | 61 |
Trovafloxacin | Trovafloxacin glucuronide | 2 | 1 | 13 | 22 |
Linezolid | Ring-opened linezolid | 1 | 2 | 45 | |
Ring-opened linezolid | 1 | 2 | 10 | ||
Sunitinib | N-Dealkyl sunitinib | 1 | 1 | 32 | 21 |
Irinotecan | Ring-opened carboxylic acid | 1 | 2 | 11 | |
Delavirdine | N-Dealkyldelavirdine | 1 | 1 | 46 | 25 |
Depyridinyl delavirdine | 1 | 1 | 38 | ||
Valdecoxib | Hydroxyvaldecoxib glucuronide | 2 | 2 | 23 | |
Valdecoxib N-glucuronide | 2 | 1 | 20 | ||
Eplerenone | 6β-Hydroxyeplerenone | 1 | 1 | 32 | 16 |
6β,21-Dihydroxeplerenone | 1 | 2 | 21 | ||
Maraviroc | Hydroxymethyl maraviroc | 1 | 1 | 13 | |
N-Desalkyl maraviroc | 1 | 2 | 22 | ||
N-Desalkyl hydroxymethyl maraviroc | 1 | 2 | 11 |